Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique

被引:53
作者
Shinde, Vikram R. [1 ]
Shelake, Makarand R. [2 ]
Shetty, Sandeep S. [1 ]
Chavan-Patil, Amit B. [1 ]
Pore, Yogesh V. [1 ]
Late, Sameer G. [3 ]
机构
[1] Govt Coll Pharm, Dept Pharmaceut Chem, Karad 415124, Maharashtra, India
[2] Bharati Vidyapeeths Poona Coll Pharm, Pune 411001, Maharashtra, India
[3] Mercer Univ, Coll Pharm & Hlth Sci, Atlanta, GA 30341 USA
关键词
D O I
10.1211/jpp.60.9.0002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The solid-state properties and dissolution behaviour of lamotrigine in its inclusion complex with beta-cyclodextrin (beta CD) and solid dispersions with polyvinylpyrrolidone K30 (PVP K30) and polyethyleneglycol 6000 were investigated. The phase solubility profile of lamotrigine with beta CD was classified as A(L)-type, indicating formation of a 1:1 stoichiometry inclusion complex, with a stability constant of 369.96 +/- 2.26 M-1. Solvent evaporation and kneading methods were used to prepare solid dispersions and inclusion complexes, respectively. The interaction of lamotrigine with these hydrophilic carriers was evaluated by powder X-ray diffractometry, Fourier transform infrared spectroscopy and differential scanning calorimetry. These studies revealed that the drug was no longer present in crystalline state but was converted to an amorphous form. Among the binary systems tested, PVP K30 (1:5) showed greatest enhancement of the solubility and dissolution of lamotrigine.
引用
收藏
页码:1121 / 1129
页数:9
相关论文
共 53 条
[1]   Study on the inclusion complexes of bromazepam with β- and β-hydroxypropyl-cyclodextrins [J].
Archontaki, HA ;
Vertzoni, MV ;
Athanassiou-Malaki, MH .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (3-4) :761-769
[2]  
Bruce J. A., 2000, J PHARM SCI, V89, P429
[3]   Cyclodextrin inclusion complexes of the central analgesic drug nefopam [J].
Brun, H. ;
Paul, M. ;
Razzouq, N. ;
Binhas, M. ;
Gibaud, S. ;
Astier, A. .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2006, 32 (10) :1123-1134
[4]   PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSION SYSTEMS [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1281-+
[5]  
Chong E, 2002, ANN PHARMACOTHER, V36, P917
[6]   Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers [J].
Cirri, M ;
Mura, P ;
Rabasco, AM ;
Ginés, JM ;
Moyano, JR ;
Gònzalez-Rodrìguez, ML .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2004, 30 (01) :65-74
[7]   PHYSICOCHEMICAL PROPERTIES OF INDOMETHACIN AND RELATED-COMPOUNDS CO-SPRAY DRIED WITH POLYVINYLPYRROLIDONE [J].
CORRIGAN, OI ;
HOLOHAN, EM ;
REILLY, MR .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1985, 11 (2-3) :677-695
[8]   Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14 [J].
Damian, F ;
Blaton, N ;
Naesens, L ;
Balzarini, J ;
Kinget, R ;
Augustijns, P ;
Van den Mooter, G .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 10 (04) :311-322
[9]   Complexation of the interferon inducer, bropirimine, with hydroxypropyl-β-cyclodextrin [J].
Echezarreta-López, M ;
Torres-Labandeira, JJ ;
Castiñeiras-Seijo, L ;
Santana-Penín, L ;
Vila-Jato, JL .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 9 (04) :381-386
[10]   Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds [J].
Fernandes, CM ;
Vieira, MT ;
Veiga, FJB .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 15 (01) :79-88